Show simple item record

dc.contributor.authorZhang, Wei
dc.contributor.authorGungor, Zeynep
dc.contributor.authorEnkhmaa, Byambaa
dc.contributor.authorKim, Kyoungmi
dc.contributor.authorBerglund, Lars
dc.contributor.authorAnuurad, Erdembileg
dc.date.accessioned2021-03-05T20:43:28Z
dc.date.available2021-03-05T20:43:28Z
dc.date.issued2012
dc.identifier.citationGungor Z., Anuurad E., Enkhmaa B., Zhang W., Kim K., Berglund L., "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk", ATHEROSCLEROSIS, cilt.223, ss.230-234, 2012
dc.identifier.issn0021-9150
dc.identifier.othervv_1032021
dc.identifier.otherav_d5884d73-64a0-44d1-b2b4-75306e38cd13
dc.identifier.urihttp://hdl.handle.net/20.500.12627/140896
dc.identifier.urihttps://doi.org/10.1016/j.atherosclerosis.2012.04.021
dc.description.abstractObjective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E-4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleApo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk
dc.typeMakale
dc.relation.journalATHEROSCLEROSIS
dc.contributor.departmentUniversity of California System , ,
dc.identifier.volume223
dc.identifier.issue1
dc.identifier.startpage230
dc.identifier.endpage234
dc.contributor.firstauthorID204931


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record